SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals.

Autor: Coyle PV; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.; Biomedical Research Center, Qatar University, Doha, P.O. Box 2713, Qatar.; Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, BT7 1NN United Kingdom., Chemaitelly H; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, P.O. Box 24144, Doha, Qatar.; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, P.O. Box 24144, Qatar., Ben Hadj Kacem MA; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Abdulla Al Molawi NH; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., El Kahlout RA; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Gilliani I; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Younes N; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Al Anssari GAAA; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Al Kanaani Z; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Al Khal A; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Al Kuwari E; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Butt AA; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY 10065, USA., Jeremijenko A; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Kaleeckal AH; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Latif AN; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Shaik RM; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Abdul Rahim HF; College of Health Sciences, QU Health, Qatar University, Doha, P.O. Box 2713, Qatar., Nasrallah GK; Biomedical Research Center, Qatar University, Doha, P.O. Box 2713, Qatar.; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, P.O. Box 2713, Qatar., Yassine HM; Biomedical Research Center, Qatar University, Doha, P.O. Box 2713, Qatar.; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, P.O. Box 2713, Qatar., Al Kuwari MG; Primary Health Care Corporation, Doha, P.O. Box 26555, Qatar., Al Romaihi HE; Ministry of Public Health, Doha, P.O. Box 42, Qatar., Al-Thani MH; Ministry of Public Health, Doha, P.O. Box 42, Qatar., Bertollini R; Ministry of Public Health, Doha, P.O. Box 42, Qatar., Abu-Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, P.O. Box 24144, Doha, Qatar.; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, P.O. Box 24144, Qatar.; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY 10065, USA.

Publikováno v: IScience [iScience] 2021 Jun 25; Vol. 24 (6), pp. 102646. Date of Electronic Publication: 2021 May 24.